Martingale Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.44M Buy
2025
Q1
$2.72M Buy
2024
Q4
$2.32M Buy
2024
Q3
$1.73M Buy
2022
Q4
Sell
2022
Q3
$725K Sell
2022
Q2
$714K Buy